|
PRMT5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
4.21019999974348E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
3.278000E-02 |
| Stage1-vs-Stage3 |
7.792400E-01 |
| Stage1-vs-Stage4 |
2.705200E-01 |
| Stage2-vs-Stage3 |
3.815600E-02 |
| Stage2-vs-Stage4 |
1.404020E-02 |
| Stage3-vs-Stage4 |
4.080600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.88199999923344E-08 |
| Normal-vs-Asian |
1.79378734088687E-12 |
| Caucasian-vs-AfricanAmerican |
3.253000E-01 |
| Caucasian-vs-Asian |
9.303400E-01 |
| AfricanAmerican-vs-Asian |
4.042800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
6.614000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62547753035369E-12 |
| Normal-vs-Age(81-100Yrs) |
5.94139999999799E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.960600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.323600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.770600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.636600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.559200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.689400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.304500E-02 |
| Classical-VS-Follicular |
8.686000E-01 |
| Classical-VS-Other |
1.678360E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
1.514170E-01 |
| Tall-VS-Other |
7.271000E-01 |
| Tall-VS-Normal |
5.55111512312578E-16 |
| Follicular-VS-Other |
3.738000E-01 |
| Follicular-VS-Normal |
6.23057161419638E-13 |
| Other-VS-Normal |
1.91549999994933E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
9.791200E-04 |
|
|
